BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11230792)

  • 1. Interaction of estrogen replacement therapy with the thrombophilic 20210 G/A prothrombin gene mutation for atherothrombotic vascular disease: a cross-sectional study of 275 hyperlipidemic women.
    Glueck CJ; Wang P; Fontaine RN; Sieve-Smith L; Lang JE
    Metabolism; 2001 Mar; 50(3):360-5. PubMed ID: 11230792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy, thrombophilia, and atherothrombosis.
    Glueck CJ; Wang P; Fontaine RN; Sieve-Smith L; Lang JE
    Metabolism; 2002 Jun; 51(6):724-32. PubMed ID: 12037725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C).
    Glueck CJ; Wang P; Fontaine RN; Tracy T; Sieve-Smith L; Lang JE
    Am J Cardiol; 1999 Sep; 84(5):549-54. PubMed ID: 10482153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of heritable and estrogen-induced thrombophilia: possible etiologies for ischemic optic neuropathy and ischemic stroke.
    Glueck CJ; Fontaine RN; Wang P
    Thromb Haemost; 2001 Feb; 85(2):256-9. PubMed ID: 11246543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
    Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
    Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J
    Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
    Bank I; Libourel EJ; Middeldorp S; Van Pampus EC; Koopman MM; Hamulyák K; Prins MH; Van Der Meer J; Büller HR
    Arch Intern Med; 2004 Sep; 164(17):1932-7. PubMed ID: 15451770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
    Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J
    Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma.
    Pihusch R; Danzl G; Scholz M; Harich D; Pihusch M; Lohse P; Hiller E
    Cancer; 2002 Jun; 94(12):3120-6. PubMed ID: 12115343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
    Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
    Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygotes for prothrombin gene 20210 A allele in a thrombophilic family without clinical manifestations of venous thromboembolism.
    Souto JC; Mateo J; Soria JM; Llobet D; Coll I; Borrell M; Fontcuberta J
    Haematologica; 1999 Jul; 84(7):627-32. PubMed ID: 10406905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilia-hypofibrinolysis and atherothrombotic cardiovascular disease < or = age 45 years.
    Glueck CJ; Munjal J; Aregawi D; Agloria M; Winiarska M; Khalil Q; Wang P
    Transl Res; 2007 Aug; 150(2):93-100. PubMed ID: 17656328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombophilic risk factors and peripheral arterial disease severity.
    Sartori M; Favaretto E; Legnani C; Cini M; Conti E; Amato A; Palareti G
    Thromb Haemost; 2010 Jul; 104(1):71-7. PubMed ID: 20390230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia.
    Heylen E; Miljic P; Willemse J; Djordjevic V; Radojkovic D; Colovic M; Elezovic I; Hendriks D
    Thromb Res; 2009 Sep; 124(4):427-32. PubMed ID: 19195685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.